Warburg Pincus adds med tech entrepreneur-in-residence; Cardiac Dimensions tops up round to $28.5M;

@FierceMedDev: This week's issue of FierceDiagnostics is out! Sign up for free here. | Follow @FierceMedDev

@VarunSaxena2: Flowonix submits MRI-compatible implantable infusion pump for FDA approval. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Robot-assisted surgery often comes with more complications and higher costs, according to new study. More from the WSJ | Follow @EmilyWFierce

@MichaelGFierce: From our Women in Biotech Feature: Adelene Perkins of $INFI says, "Our endeavor is by definition a team sport." More | Follow @MichaelGFierce

> Cardiac Dimensions, a company specializing in minimally invasive treatments for cardiovascular conditions, added $8.5 million to bring its latest venture round to a total of $28.5 million. Release

> Private equity firm Warburg Pincus appointed experienced med tech executive Dr. Richard Hassett as an executive-in-residence for its healthcare group. Release

> The FDA approved MOZART with TomoSpec, a breast specimen radiography system with tomosynthesis technology, created by Kubtec, developer of digital specimen radiography systems. Release

Biotech News

@FierceBiotech: New special report: Top 7 life sciences public investors. Feature | Follow @FierceBiotech

@JohnCFierce: BIA did a report on bio-fundraising in the U.K. Hard to see where the promo ends and the analysis begins. Very Yank. More | Follow @JohnCFierce

@DamianFierce:  | Follow @DamianFierce

@EmilyMFierce: Hmmm... Cancer tumours destroyed by berry found in Queensland rainforest. More from The Guardian | Follow @EmilyMFierce

> Buzz: Unsated by its Durata deal, Actavis looks again to buy Allergan. More

> Levicept emerges from Pfizer's R&D ashes with $20M and a new pain drug. Story

> Amgen declares a head-to-head PhIII win for Humira biosimilar. News

> Chimerix scores promising antiviral data from a controversy-fueled PhIII pilot. Article

Pharma News

@FiercePharma: Top-read special report in FP Tues: Top 10 pharma companies by employees - 2014. Feature | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Bayer insists its probiotic marketing claims aren't full of hot air. Article | Follow @CarlyHFierce

> Novartis, GSK shake up executive ranks as overhaul continues. Article

> With Actavis poised to swoop in, Valeant eyes $4.5B hike in bid for Allergan. Report

Drug Delivery News

> Flat nanosheets roll drugs up and release them on command. Item

> With Roche's Herceptin, green tea component doubles drug accumulation in cancer cells. More

> Flowonix submits MRI-compatible implantable infusion pump for FDA approval. Story

> USPTO to review delivery patent in spat between Suboxone and BDSI's Bunavail. Report

> Alnylam says it wants to enter larger disease areas using partnership-driven approach. More

Diagnostics News

> MD Anderson pursues two projects targeting personalized prostate cancer testing. News

> Health Diagnostic Laboratory helps find promising predictive diabetes biomarkers. More

> Swedes, Harvard and more find success with DNA test for Afib risks. Report

> NanoString and a Harvard-affiliated hospital hope to quicken creation of new cancer tests. Story

> Quest, in transition, recruits Mayo Clinic exec to run major division. Article

Pharma Marketing News

> Analysts: Actavis-Allergan deal could create a marketing superpower. Item

> Pfizer's new #viagracommercial lights up Twitter during MLB playoffs--and not in a good way. More

> Merck hops onto HBCU network to step up its brand in the African-American community. Report

> Hand out prizes for adherence? West and HealthPrize team up to test the idea. Story

> Balking at marketing slapdown, Galderma declares itself pharma non grata. Article

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.